Andrew McClintock

No ORCID on file · 1 paper in corpus
other 2022
Frontiers in oncology ·doi:10.3389/fonc.2022.727505

BACKGROUND: Aldo-keto reductase 1B10 (AKR1B10) is a secretory protein that is upregulated in breast cancer. OBJECTIVE: This case-controlled pilot study evaluated the serum level of AKR1B10 in healthy women and patients with a localized or …